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A B S T R A C T
We present two cases of keratitis due to Metarhizium anisopliae in geographically separated areas of the United
States. The isolates were microscopically similar but morphologically diﬀerent and were identiﬁed by ribosomal
DNA sequencing. Both isolates had low minimum inhibitory concentration (MIC) values to caspofungin and
micafungin, but high MIC values to amphotericin B. The morphologic and antifungal susceptibility diﬀerences
between the two isolates indicate possible polyphylogeny of the group.
1. Introduction
Metarhizium anisopliae is an entomopathogenic ﬁlamentous fungus
that is a plant symbiont and is found in soil throughout the world [1]. It
causes disease in a wide variety of insects and other arthropods and is
used commercially as an agricultural pesticide in many countries, in-
cluding the United States (US) [1]. Previously, M. anisopliae was not
considered to be pathogenic to humans due to its optimal growth
temperature of 25 °C [2], however, human infection has been reported
in the literature. Most of the cases have been ophthalmic infections with
additional cases of fungal sinusitis and disseminated fungemia. The ﬁrst
reported case occurred in Columbia, South America in 1997 and was a
fungal keratitis in an 18-year-old man [3]. There have now been four
reported cases of fungal keratitis [3–6] and two cases of sclerokeratitis
[7,8]. Here we report two additional cases of Metarhizium keratitis in
soft contact lens wearers.
2. Case
The ﬁrst case is a 47-year-old woman from Georgia, US, who pre-
sented to Emory University Hospital (Day 0) with severe pain, foreign
body sensation, and decreased visual acuity in her left eye that started
10 days prior and got progressively worse. The patient was a soft
contact lens wearer who reports poor lens hygiene and that she routi-
nely wore her contact lenses overnight. The patient had no history of
ocular disease or underlying systemic disease.
On examination (Day 0), the aﬀected eye had an approximately
2× 2mm ﬂuﬀy white inﬁltrate slightly superior and to the left of the
visual axis surrounded by scattered stromal subepithelial inﬁltrates,
1+ edema, 1+ scleral injection and a large (10mm) epithelial defect.
Visual acuity was 20/20 in the right eye and 20/200 in the left eye.
The diﬀerential diagnosis was herpes simplex virus, Acanthamoeba,
or bacterial infection, but because of the appearance of the corneal
inﬁltrates the infection was presumed to be fungal. Treatment with
topical voriconazole eye drops (10mg/mL, not commercially available,
prepared by compounding pharmacy in-house) every hour plus gati-
ﬂoxacin eye drops (5mg/mL, Zymaxid®, Allergan, Irvine, CA) four
times per day was started on Day 0 along with oral acyclovir (1 g twice
daily, Zovirax®, GlaxoSmithKline, Philadelphia, PA). Scrapings from the
corneal lesion were taken and were directly inoculated onto tryptic soy
agar with sheep blood (Remel, Lenexa, KS) and Sabouraud dextrose
agar (Remel) plates and sent to the Clinical Microbiology Laboratory for
bacterial and fungal culture. A Gram stain was not performed but
corneal scrapings evaluated in the Ophthalmic Pathology Laboratory
showed epithelial cells and septate fungal elements.
The culture plates were incubated at 30 °C in ambient air and within
three days the plates began to show growth of compact velvety colonies
along the inoculation streaks. The colonies were initially white and
gradually turned dark green on the surface and brownish orange on the
reverse (Fig. 1A, B). Tease preparations and slide culture showed nu-
merous microconidia (Fig. 2). Based on morphologic and growth
characteristics, the isolate was presumptively identiﬁed as Metarhizium
species (isolate B10964).
After three weeks (Day 21), oral voriconazole (200mg every 12 h)
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was added and the frequency of voriconazole eye drops was decreased
to four times daily. The acyclovir was discontinued due to determina-
tion of a fungal infection. Natamycin eye drops (50mg/mL,
NATACYN®, Alcon, Fort Worth, TX) every hour were administered early
in the treatment regimen, however the patient was unable to tolerate
them.
At 34 days after presentation, the patient developed inﬂammation-
associated glaucoma with intraocular pressure as high as 50mm Hg
(normal range10–21mm Hg) and visual acuity was reduced to light
perception in the left eye. The inﬂammation-associated glaucoma was
treated with trans-scleral diode laser cyclophotocoagulation.
Approximately 12 weeks after the initial visit (Day 84), superior
thinning was noted, but the inﬁltrate was improving and the size of the
epithelial defect had decreased to 4.5×2.5mm. Approximately one
week later new inﬁltrates were noted and corneal smears showed oc-
casional fungal elements. Again, scrapings from the corneal lesion were
taken and directly inoculated onto tryptic soy gar with sheep blood and
Sabouraud dextrose agar plates and sent to the Clinical Microbiology
Laboratory for bacterial and fungal culture, and once more a mould
(isolate B11041) was identiﬁed with the same characteristics as the
initial isolate (isolate B10964).
A corneal transplant was performed 13 weeks (Day 91) after the
initial visit due to persistence of fungal keratitis. There were no signs of
continued fungal infection but a cataract developed and was subse-
quently removed.
The second case is a 50-year-old man from rural Missouri, US, who
presented to his primary care provider with left eye pain (Day 0). The
pain was acute in onset (approximately one week in duration) and the
patient experienced photophobia and vision loss in the left eye. On
exam, the primary care provider noted a cloudy white area in the left
eye suspicious for fungal infection, and referred the patient to Barnes-
Jewish Hospital for further work up.
The patient reported using disposable contact lenses designed to be
worn during the day each day for two weeks, and recounted sleeping
with the lenses in place approximately three times per week. Of note, he
had been in a motor vehicle accident approximately 30 years prior and
Fig. 1. Morphologically diﬀerent colony types of the B10964 (A, B), Georgia isolate, and B11022 (C, D), Missouri isolate, Metarhizium anisopliae isolates after 7 days of growth on
Sabouraud dextrose agar at 25 °C (BBL, Becton, Dickinson and Company, Franklin Lakes, NJ). Colonies are ﬂoccose with a dense heaped center that was either light with a dark green ring
(B10964) or yellow-green (B11022), both with a white fringe. The reverse of both isolates was a brownish orange color.
Fig. 2. Lactophenol cotton blue stain of slide culture of the GeorgiaMetarhizium anisopliae
(B10964) isolate, showing slender conidiophores with verticilliate branching ending with
clavate, parallel phialides and cylindrical microconidia in chains (original magniﬁcation,
400×).
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experienced lacerations of the left eyelid at that time, and reported that
occasionally small pieces of glass emerged from this area. The patient
was initially treated with moxiﬂoxacin (5mg/mL, Vigamox®, Alcon,
Fort Worth, TX) and tobramycin/dexamethasone (3mg/mL to-
bramycin/1 mg/mL dexamethasone, Tobradex®, Alcon) drops every
hour.
At Barnes-Jewish Hospital, bacterial, viral, fungal, and acid-fast
bacillus cultures were performed, as well as culture for Acanthamoeba.
The bacterial culture grew one colony of Staphylococcus epidermidis.
Each of the fungal, bacterial, and acid fast bacillus cultures grew a
mould (Day 3) that was subsequently identiﬁed as Metarhizium aniso-
pliae by sequence analysis at the University of Texas at San Antonio
Fungus Testing Laboratory (Fig. 1 C, D) (isolate B11022).
The patient's left eye was treated with gatiﬂoxacin ophthalmic so-
lution (5mg/mL, Zymaxid®) every three hours while awake and every
four hours while asleep, prednisone four times per day, scopolamine
ophthalmic drops twice a day, and preservative free artiﬁcial tears four
times per day. Details of antifungal treatment are not known. The pa-
tient was discharged home ﬁve days following presentation to Barnes-
Jewish Hospital in stable condition.
Approximately two months later (Day 46), the patient returned to
Barnes-Jewish Hospital for follow up with persistent eye pain. A corneal
scraping from the left eye was obtained and submitted for bacterial,
fungal, and Acanthamoeba culture. Metarhizium anisopliae was again
recovered from the bacterial, fungal and mycobacterial cultures. The
cornea was resected and a half-button was submitted for histo-
pathology, which revealed abundant ﬁlamentous fungi accompanied by
a conspicuous lack of inﬂammatory cells. The patient was subsequently
followed by an outside provider.
Since the isolates from the two cases were microscopically similar
but the colonies were morphologically diﬀerent, molecular identiﬁca-
tion and phylogenetic analysis of the obtained sequences was per-
formed to further explore their relatedness. Fungal genomic DNA was
extracted from the initial isolate from Georgia (B10964) and the
Missouri isolate (B11022), the internal transcribed spacer (ITS) and D1/
D2 regions of the ribosomal DNA were ampliﬁed using PCR, and big dye
sequencing was performed as previously described [9]. The ITS and D1/
D2 sequences were aligned and the combined sequence was used for
species identiﬁcation using the BLAST function of the National Center
for Biotechnology Information (NCBI) database (https://www.ncbi.
nlm.nih.gov). The resulting sequence alignments were used to con-
struct a neighbor-joining tree using Geneious 8.1.6 (Biomatters Ltd.,
San Francisco, CA). Sequences have been deposited in the NCBI data-
base (accession numbers MF435927 and MF435928).
Phylogenetic analysis showed the isolates from both cases ﬁt into a
group consistent with Metarhizium anisopliae (Fig. 3), although the high
degree of sequence variation within the group indicates this may not be
a monophyletic group and could be divided in the future with the
isolates from the two cases belonging to separate clades.
Antifungal susceptibility testing was performed using standardized
Clinical and Laboratory Standards Institute broth microdilution meth-
odology as described in document M38-A2 [10] with the exception of
amphotericin B which was assayed using gradient diﬀusion (Etest;
bioMérieux, Durham, NC). Due to poor growth at 37 °C, minimum in-
hibitory concentration (MIC) values were recorded after 48 h of in-
cubation at 30 °C. Reference strains Aspergillus fumigatus ATCC® MYA
3626 and Purpurocilium lilacinus ATCC® MYA 3630 were tested con-
currently and the resultant MIC values for the antifungal agents tested
were within the expected ranges for quality control.
There is a considerable diﬀerence between the susceptibility proﬁles
of the Georgia (B10964 and B11041) and Missouri (B11022) isolates
(Table 1). The isolates from both locations had low MIC values to
caspofungin, micafungin, and anidulafungin, but very high MIC values
to amphotericin B. The MIC values for voriconazole and posaconazole
for all isolates tested were between 0.12 and 4 µg/mL, with the Missouri
isolate (B11022) exhibiting lower MIC values than the Georgia isolates
(B10964 and B11041). It is interesting that the Missouri isolate had a
low MIC value to ﬂuconazole (4 µg/mL), which should have no activity
against moulds, but the Georgia isolate had a very high MIC value
(> 256 µg/mL). Similarly, the Missouri isolate had a low MIC value to
itraconazole (0.5 µg/mL) but the Georgia isolate had a very high MIC
value (> 16 µg/mL). These data are again consistent with the possible
future separation of the Metarhizium group.
3. Discussion
Metarhizium anisopliae is a ubiquitous fungus capable of saprophytic
growth in soil and parasitic growth in many insect species [1]. Due to
its use as an agricultural pesticide, exposure may be common. However,
no cases of M. anisopliae infection have been associated with its use as a
pesticide and how human infection with M. anisopliae becomes estab-
lished is not clear [2].
It was noted by Eguchi et al. that all cases of M. anisopliae keratitis
and sclerokeratitis have occurred in extratropical climates which is
unusual as most fungal keratitis infections develop in tropical climates
[8]. This may be due to the lower optimal growth temperature of 25 °C
(range 15–30 °C) for M. anisopliae, although some isolates survive
temperatures up to 35–40 °C [11]. Our isolates all grew at 30 °C but
failed to grow at 37 °C. Ophthalmic infections are the most common
human infection for M. anisopliae occurring to date, possibly due to the
Fig. 3. Neighbor-joining tree of combined ITS and D1/D2 regions of the ribosomal cis-
tron. Alpha-numeric numbers are NCBI accession numbers.
Table 1
Antifungal susceptibility testing results for the Metarhizium anisopliae isolates.
Strain MIC values (µg/mL)a
AMP B FLU VORI ITRA POSA CASPO ANID MICA
B10964 >32 >256 2 >16 2 0.06 1 <0.008
B11041 >32 >256 2 >16 4 0.06 1 0.015
B11022 >32 4 0.25 0.5 0.12 0.06 1 <0.008
Abbreviations: AMP B, amphotericin B: FLU, ﬂuconazole: VORI, voriconazole; ITRA,
itraconazole; POSA, posaconazole; CASPO, caspofungin; ANID, anidulafungin; MICA,
micafungin.
a Antifungal susceptibility testing performed using broth microdilution, except for
amphotericin B gradient diﬀusion testing.
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lower normal corneal temperature, which ranges from 32.5 °C to
36.5 °C [5,8]. Additionally, there have been two documented cases of
sinusitis, with the normal temperature in the maxillary sinus around
34 °C [12]. This may suggest that M. anisopliae is better able to thrive
and establish an infection in areas of the body with a lower basal
temperature. Prior injury does not appear to be required for inocula-
tion, however, both patients described here and the majority of pre-
vious reports occurred in soft contact lens wearers which may suggest
this increases vulnerability to M. anisopliae keratitis.
There have been three reported cases of cutaneous M. anisopliae
infection, all occurring in immunocompromised individuals (two chil-
dren and one adult) [11–13]. Disseminated infection was suspected in
two of these cases (one child and one adult) as evidenced by multiple
culture-positive skin lesions [13,14]. Brain and lung abscesses con-
sistent with fungal infection were seen on a computed tomography scan
in one of the cases and were presumed to be caused by M. anisopliae
[13]. No obvious portal of entry was identiﬁed in either case.
Topical natamycin is usually considered the most eﬀective treat-
ment for ocularM. anisopliae infections [8], although there is no clinical
or microbiological evidence that it is any more eﬀective than ampho-
tericin B. Many of the cases of M. anisopliae prior to identiﬁcation were
initially treated with amphotericin B. Antifungal susceptibility testing
on the three corneal isolates from the cases presented here as well as in
previous studies on an ocular isolate, a skin lesion isolate, two isolates
causing sinusitis, and three isolates recovered from bronchoalveloar
lavage specimens revealed high MIC values to amphotericin B
(≥ 16 µg/mL) [8,11,15]. Additionally, when tested, 5-ﬂuorocytosine
(5-FC) also had high MIC values (> 64 µg/mL) [8,15]. Consistent with
these in vitro ﬁndings, one case of disseminated M. anisopliae treated
with amphotericin B and 5-FC did not result in clinical improvement
[13]. Interestingly, a tablet diﬀusion method (Neo-Sensitabs, Rosco
Diagnostica, Taastrup, Denmark) of susceptibility testing suggested that
the organism was susceptible to amphotericin B but resistant to azole
agents [13]. Both reported cases of sclerokeratitis had unfavorable re-
sponses to multidrug antifungal therapy even though natamycin was
included in the regimen, and ultimately required therapeutic corneal
transplant [7,8]. Corneal transplant was also required in the two ker-
atitis cases reported here as well as in one previously reported case [6].
Caspofungin and micafungin may be eﬀective agents for ocular and
other infections since corneal penetration is adequate after systemic
administration [16,17], and susceptibility testing in the current study
and in previous reports demonstrated MIC values (0.25 µg/mL or lower)
that suggested M. anisopliae would be susceptible [8,11]. Anidulafungin
also had low MIC values (1 µg/mL) for the isolates in the current study
but was not evaluated in other studies.
The azoles (itraconazole, voriconazole, posaconazole, miconazole,
and ﬂuconazole) and SCH 56592 had variable MIC values and anti-
fungal susceptibility testing may help to inform individual treatment
decisions if these agent are considered [8,11,15]. Intravenous vor-
iconazole failed to improve a skin lesion due to an isolate that exhibited
an MIC value of 2 µg/mL, and the lesion was subsequently excised [11].
Itraconazole did produce a clinical response in a case report of a cat
with invasive disease, however relapse occurred after discontinuation
of therapy [18].
The poor treatment outcomes emphasize that early diagnosis and
increased understanding of the antifungal susceptibility proﬁle of M.
anisopliae isolates is required. The phenotypic and genotypic diﬀerences
between the isolates described here indicate that M. anisopliae may be a
species complex and the diﬀerential susceptibilities are an indication
that a distinction of isolates within the complex may have clinical im-
plications.
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